Vishala Chindalore is a Rheumatology/Immunology physician. OpenAlex indexes 26 publications with 1,179 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1010 Christine Ave
Anniston, AL 362075710
Telephone
256-236-5631Registry record last updated 16 Apr 2008.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202527 payments
- Amgen Inc.Program year202530 payments
- UCB, Inc.Program year202519 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
62%TNF inhibitor51%Golimumab87%Infliximab12%Humira(Cf) Pen0%Enbrel Mini0%Enbrel Sureclick0%Humira Pen0%Enbrel0%Humira0%Part D + Part B<11 patientsSelective T Cell Costimulation Modulator8.8%Abatacept100%Orencia0%Part D + Part B<11 patients+ 8 more classes in this area
Musculoskeletal
30.2%RANK Ligand Inhibitor14.6%Denosumab100%Part B, office-administered≥138 patientsOther drugs affecting bone structure and mineralization14.2%Romosozumab-aqqg100%Part B, office-administered≥12 patients+ 8 more classes in this area
Metabolism & gastrointestinal
2.3%Corticosteroid1.2%Prednisone100%Part D≥301 patientsAminosalicylate0.9%Sulfasalazine98%Sulfasalazine Dr2%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”